NYSE: VIE - Viela Bio, Inc.

Yield per half year: +99.66%
Sector: Healthcare

Company Analysis Viela Bio, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (99.66%) is higher than the sector average (15.6%).
  • The company's current efficiency (ROE=-41.26%) is higher than the sector average (ROE=-80.89%)

Disadvantages

  • Price (53.01 $) is higher than fair price (29.11 $)
  • Dividends (0%) are below the sector average (1.22%).

Similar companies

Allergan

PFIZER

PerkinElmer

Danaher Corporation

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Viela Bio, Inc. Healthcare Index
7 days 99.7% -28.7% 4%
90 days 99.7% -0% 12%
1 year 99.7% 15.6% 36.3%

VIE vs Sector: Viela Bio, Inc. has outperformed the "Healthcare" sector by 84.06% over the past year.

VIE vs Market: Viela Bio, Inc. has outperformed the market by 63.33% over the past year.

Slightly volatile price: VIE is more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical deviations of about +/- 5-15% per week.

Long period: VIE with weekly volatility of 1.92% over the past year.

3. Summary of the report

3.1. General

P/E: 0
P/S: 249.99

3.2. Revenue

EPS -103.07
ROE -41.26%
ROA -23.83%
ROIC 0%
Ebitda margin 0%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (53.01 $) is higher than the fair price (29.11 $).

Price is higher than fair: The current price (53.01 $) is 45.1% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (58.16).

P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.31).

4.3. P/BV

P/BV vs Sector: The company's P/BV (4.87) is lower than that of the sector as a whole (9.41).

P/BV vs Market: The company's P/BV (4.87) is lower than that of the market as a whole (22.52).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (249.99) is higher than that of the sector as a whole (4.08).

P/S vs Market: The company's P/S indicator (249.99) is higher than that of the market as a whole (15.08).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (-16.72) is lower than that of the sector as a whole (17.46).

EV/Ebitda vs Market: The company's EV/Ebitda (-16.72) is lower than that of the market as a whole (22.73).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 14.88% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (14.88%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-14.29%).

5.4. ROE

ROE vs Sector: The company's ROE (-41.26%) is higher than that of the sector as a whole (-80.89%).

ROE vs Market: The company's ROE (-41.26%) is lower than that of the market as a whole (17.15%).

5.5. ROA

ROA vs Sector: The company's ROA (-23.83%) is lower than that of the sector as a whole (6.64%).

ROA vs Market: The company's ROA (-23.83%) is lower than that of the market as a whole (6.59%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.68%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.31%).

6. Finance

6.1. Assets and debt

Debt level: (0%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 0%.

Excess of debt: The debt is not covered by net income, percentage -1.53%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '1.22%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Viela Bio, Inc.